Abiopharma

ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Reborn Coffee Signs $20 Million Annual Supply Agreement with The Mighty Oak, Strengthening Its Revenue Base and Profitability Through the Conversion of Existing Supply Volume

Ascendis Pharma Reports Second Quarter 2026 Financial Results

DEFSEC Technologies Inc. Announces Third Quarter Fiscal 2026 Results

UTStarcom Announces Finance Leadership Changes

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012291 <b>Size:</b> 83 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023654 <b>Size:</b> 614 KB

New Form SCHEDULE 13G/A - Genpact LTD <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000188 <b>Size:</b> 8 KB

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023651 <b>Size:</b> 779 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023652 <b>Size:</b> 1 MB

New Form FWP - CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023653 <b>Size:</b> 74 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023650 <b>Size:</b> 987 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023649 <b>Size:</b> 693 KB

New Form SCHEDULE 13G/A - GARTNER INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000187 <b>Size:</b> 8 KB